• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,503.60 -1,677.12
( -2.15%)
Global Indices
Nasdaq
52,927.94 -148.97
(-0.28%)
Dow Jones
7,522.05 -36.38
(-0.48%)
Hang Seng
67,213.51 -1,043.45
(-1.53%)
Nikkei 225
10,685.41 33.64
(0.32%)
Forex
USD-INR
95.36 0.17
(0.18%)
EUR-INR
108.98 0.13
(0.12%)
GBP-INR
127.38 0.36
(0.28%)
JPY-INR
0.59 0.00
(-0.24%)

EQUITY - MARKET SCREENER

Sunrest Lifescience Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
91669
INE0PLZ01012
27.4543251
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNREST
9.89
30.55
EPS(TTM)
Face Value()
Div & Yield %
3.6
10
0
 

kotia enterprises ltd
Fredun Pharmaceuticals standalone net profit rises 56.58% in the March 2026 quarter
May 25,2026
Net profit of Fredun Pharmaceuticals rose 56.58% to Rs 11.07 crore in the quarter ended March 2026 as against Rs 7.07 crore during the previous quarter ended March 2025. Sales rose 27.18% to Rs 210.41 crore in the quarter ended March 2026 as against Rs 165.44 crore during the previous quarter ended March 2025.

For the full year,net profit rose 59.59% to Rs 33.21 crore in the year ended March 2026 as against Rs 20.81 crore during the previous year ended March 2025. Sales rose 40.21% to Rs 633.33 crore in the year ended March 2026 as against Rs 451.71 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales210.41165.44 27 633.33451.71 40
OPM %13.8510.54 -14.9712.20 -
PBDT14.659.29 58 55.5032.72 70
PBT11.548.04 44 47.5928.27 68
NP11.077.07 57 33.2120.81 60